FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385409121> ?p ?o ?g. }

• W4385409121 endingPage "1380" @default.
• W4385409121 startingPage "1372" @default.
• W4385409121 abstract "The current study was designed to investigate the influence of allosteric effectors on the metabolism of the prototypical cytochrome P450 (CYP) 3A4 substrate midazolam (MDZ), and on the determination in vitro time-dependent inhibition (TDI) of CYP3A4 using human liver microsomes (HLM). As the concentration of midazolam increased to 250 <i>µ</i>M in HLMs, homotropic cooperativity resulted in a decrease in the 1’-hydroxymidazolam to 4-hydroxymidazolam ratio to a maximum of 1.1. The presence of varying concentrations of testosterone, progesterone (PGS), or carbamazepine (CBZ) in HLMs with MDZ could recapitulate the effect of homotropic cooperativity such that the formation rates of the 1’hydroxymidazolam and 4-hydroxymidazolam were equal even at low concentrations of MDZ. The presence of PGS (10 or 100 <i>µ</i>M) and CBZ (100 or 1000 <i>µ</i>M) in in vitro TDI determination of four known CYP3A4 time-dependent inactivators (clarithromycin, troleandomycin, mibefradil, raloxifene) simultaneously decreased potency and inactivation rate constant, resulting in fold changes in inactivation efficiency on average of 1.6-fold and 13-fold for the low and high concentrations of allosteric modulator tested, respectively. The formation of a metabolic-intermediate complex (MIC) for clarithromycin and troleandomycin decreased in the presence of the allosteric modulators in a concentration-dependent manner, reaching a new steady state formation that could not be overcome with increased incubation time. Maximum reduction of the MIC formed by clarithromycin was up to ∼91%, while troleandomycin MIC decreased up to ∼31%. These findings suggest that the absence of endogenous allosteric modulators may contribute to the poor translation of HLM-based drug–drug interaction predictions. <h3>SIGNIFICANCE STATEMENT</h3> The reported overprediction of in vitro human liver microsome time-dependent inhibition of CYP3A4 and observed drug interactions in vivo remains an issue in drug development. We provide characterization of allosteric modulators on the CYP3A4 metabolism of the prototypical substrate midazolam, demonstrating the ability of the modulators to recapitulate the homotropic cooperativity of midazolam. Furthermore, we demonstrate that allosteric heterotropic cooperativity of CYP3A4 can impact the time-dependent inhibition kinetics of known mechanisms-based inhibitors, providing a potential mechanism to explain the overprediction." @default.
• W4385409121 created "2023-08-01" @default.
• W4385409121 creator A5000765335 @default.
• W4385409121 creator A5002810024 @default.
• W4385409121 creator A5004449985 @default.
• W4385409121 creator A5027358490 @default.
• W4385409121 creator A5047722150 @default.
• W4385409121 date "2023-07-31" @default.
• W4385409121 modified "2023-09-27" @default.
• W4385409121 title "Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4" @default.
• W4385409121 cites W1741338572 @default.
• W4385409121 cites W1972327861 @default.
• W4385409121 cites W1985984753 @default.
• W4385409121 cites W1987542967 @default.
• W4385409121 cites W1993361581 @default.
• W4385409121 cites W1999227893 @default.
• W4385409121 cites W2000966246 @default.
• W4385409121 cites W2006946795 @default.
• W4385409121 cites W2010427019 @default.
• W4385409121 cites W2015728154 @default.
• W4385409121 cites W2036334470 @default.
• W4385409121 cites W2043048138 @default.
• W4385409121 cites W2068422015 @default.
• W4385409121 cites W2076638657 @default.
• W4385409121 cites W2084757915 @default.
• W4385409121 cites W2086746579 @default.
• W4385409121 cites W2090968259 @default.
• W4385409121 cites W2122651109 @default.
• W4385409121 cites W2126345597 @default.
• W4385409121 cites W2126748047 @default.
• W4385409121 cites W2139738217 @default.
• W4385409121 cites W2141587192 @default.
• W4385409121 cites W2143836494 @default.
• W4385409121 cites W2145352768 @default.
• W4385409121 cites W2152381833 @default.
• W4385409121 cites W2156423252 @default.
• W4385409121 cites W2157421942 @default.
• W4385409121 cites W2158184277 @default.
• W4385409121 cites W2164113828 @default.
• W4385409121 cites W2164586956 @default.
• W4385409121 cites W2164993892 @default.
• W4385409121 cites W2269712095 @default.
• W4385409121 cites W2319704017 @default.
• W4385409121 cites W2416570752 @default.
• W4385409121 cites W2567127730 @default.
• W4385409121 cites W2602060348 @default.
• W4385409121 cites W2811069189 @default.
• W4385409121 cites W2915943436 @default.
• W4385409121 cites W2945094539 @default.
• W4385409121 cites W2949507904 @default.
• W4385409121 cites W2981277841 @default.
• W4385409121 cites W3002831763 @default.
• W4385409121 cites W3151537290 @default.
• W4385409121 cites W3160505939 @default.
• W4385409121 cites W4283211422 @default.
• W4385409121 doi "https://doi.org/10.1124/dmd.123.001382" @default.
• W4385409121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37524542" @default.
• W4385409121 hasPublicationYear "2023" @default.
• W4385409121 type Work @default.
• W4385409121 citedByCount "0" @default.
• W4385409121 crossrefType "journal-article" @default.
• W4385409121 hasAuthorship W4385409121A5000765335 @default.
• W4385409121 hasAuthorship W4385409121A5002810024 @default.
• W4385409121 hasAuthorship W4385409121A5004449985 @default.
• W4385409121 hasAuthorship W4385409121A5027358490 @default.
• W4385409121 hasAuthorship W4385409121A5047722150 @default.
• W4385409121 hasBestOaLocation W43854091211 @default.
• W4385409121 hasConcept C109650736 @default.
• W4385409121 hasConcept C166014724 @default.
• W4385409121 hasConcept C166342909 @default.
• W4385409121 hasConcept C181199279 @default.
• W4385409121 hasConcept C185592680 @default.
• W4385409121 hasConcept C2776038425 @default.
• W4385409121 hasConcept C526171541 @default.
• W4385409121 hasConcept C55493867 @default.
• W4385409121 hasConcept C62231903 @default.
• W4385409121 hasConcept C86803240 @default.
• W4385409121 hasConcept C98274493 @default.
• W4385409121 hasConceptScore W4385409121C109650736 @default.
• W4385409121 hasConceptScore W4385409121C166014724 @default.
• W4385409121 hasConceptScore W4385409121C166342909 @default.
• W4385409121 hasConceptScore W4385409121C181199279 @default.
• W4385409121 hasConceptScore W4385409121C185592680 @default.
• W4385409121 hasConceptScore W4385409121C2776038425 @default.
• W4385409121 hasConceptScore W4385409121C526171541 @default.
• W4385409121 hasConceptScore W4385409121C55493867 @default.
• W4385409121 hasConceptScore W4385409121C62231903 @default.
• W4385409121 hasConceptScore W4385409121C86803240 @default.
• W4385409121 hasConceptScore W4385409121C98274493 @default.
• W4385409121 hasIssue "10" @default.
• W4385409121 hasLocation W43854091211 @default.
• W4385409121 hasLocation W43854091212 @default.
• W4385409121 hasOpenAccess W4385409121 @default.
• W4385409121 hasPrimaryLocation W43854091211 @default.
• W4385409121 hasRelatedWork W2043048138 @default.
• W4385409121 hasRelatedWork W2046910621 @default.
• W4385409121 hasRelatedWork W2093857837 @default.
• W4385409121 hasRelatedWork W2100024810 @default.

• next